Hôpital HURIEZ - Chirurgie digestive et transplantation
Lille, France
Location status: Recruiting
Location contact
philippe ZERBIB, Pr
CONTACT
NCT Number: NCT05577143
Multicenter, inter-regional, case-control study with the primary objective of evaluating the discriminative power of the blood biomarker TFPI-1 to separate patients with histologically proven CRC from an asymptomatic control population between 50 and 75 years of age with normal colonoscopy.
Interested in participating?
Request Info18 year–75 year
All sexes
Observational
Lille, France
Location status: Recruiting
philippe ZERBIB, Pr
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Note.
Exclusion criteria
Time frame: At 2 months
the AUC of the TFPI-1 biomarker to separate the 2 groups (CRC+ and control, i.e., asymptomatic population between 50 and 75 years with normal colonoscopy).
Time frame: At 2 months
Time frame: At 2 months
Time frame: At 2 months
Contact information is provided by the study sponsor or research team.
University Hospital, Lille
Other
Evaluation of the Discriminatory Role of Blood TFPI-1 and TFPI-2 in Adult Colorectal Cancer
Acronym: BACCHUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04258813
Adenocarcinoma, Adnexal Diseases
Durham, North Carolina, United States
View Trial DetailsNCT04074460
Breast Diseases, Breast Neoplasms
Melbourne, Australia
View Trial DetailsNCT07091032
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT04592003
Cancer Colorectal, Colonic Diseases
Amiens, France
View Trial Details